Behavioral Intervention for Ovary Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Karmanos Cancer Institute at McLaren Clarkston, Clarkston, MI
Ovary Cancer+32 More
Behavioral Intervention - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This study is evaluating whether a communication brochure can improve communication between patients and doctors.

See full description

Eligible Conditions

  • Ovary Cancer
  • Breast Cancer, Stage III
  • Lung carcinoma cell type unspecified stage IV
  • Stage III Ovarian Cancer
  • Breast Cancer, Stage II
  • Stage IV Colorectal Cancer
  • Stage III Prostate Cancer
  • Stage II Bladder Cancer
  • Stage III Bladder Cancer
  • Stage IV Prostate Cancer
  • Carcinoma Breast Stage IV
  • Stage III Colorectal Cancer
  • Stage II Lung Cancer
  • Stage III Lung Cancer
  • Stage II Prostate Cancer
  • Stage II Colorectal Cancer
  • Stage II Ovarian Cancer
  • Advanced Ovarian Cancer
  • Stage II Cervical Cancer
  • Stage II Kidney Cancer
  • Kidney Cancer Stage Iv
  • Cervical Cancer, Stage III
  • Metastatic Bladder Cancer
  • Stage III Kidney Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Ovary Cancer

Study Objectives

This trial is evaluating whether Behavioral Intervention will improve 1 primary outcome and 4 secondary outcomes in patients with Ovary Cancer. Measurement will happen over the course of Post-meeting (Time 3).

Baseline (Time 1) to post-clinic visit (Time 3)
Change in trust in physicians
Baseline (Time 1) to pre-clinic visit (TIme 2) post-clinic visit (TIme 3)
Change in distress
Change in knowledge related to the patient's cancer and treatment
Self-efficacy in managing patient-physician interactions
Post-meeting (Time 3)
Perceptions of the Question Prompt List

Trial Safety

Safety Progress

1 of 3

Other trials for Ovary Cancer

Side Effects for

Behavioral Intervention & DCS
Diarrhea
13%
This histogram enumerates side effects from a completed 2013 Phase 1 & 2 trial (NCT01923896) in the Behavioral Intervention & DCS ARM group. Side effects include: Diarrhea with 13%.

Trial Design

1 Treatment Group

Health services research (ASQ brochure)
1 of 1
Experimental Treatment

This trial requires 225 total participants across 1 different treatment group

This trial involves a single treatment. Behavioral Intervention is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Health services research (ASQ brochure)
Behavioral
Patients receive ASQ brochure and complete questionnaires over 30 minutes at baseline, over 10 minutes pre-clinic visit, and over 30 minutes post-clinic visit.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral Intervention
2017
Completed Phase 4
~3220

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline (time 1) to pre-clinic visit (time 2) post-clinic visit (time 3)
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly baseline (time 1) to pre-clinic visit (time 2) post-clinic visit (time 3) for reporting.

Who is running the study

Principal Investigator
S. E.
Susan Eggly, Principal Investigator
Barbara Ann Karmanos Cancer Institute

Closest Location

Karmanos Cancer Institute at McLaren Clarkston - Clarkston, MI

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. You must have received newly diagnosed for Ovary Cancer or one of the other 32 conditions listed above. There are 4 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Adults 18 years of age or older
Have a first appointment to see a medical oncologist at a Karmanos Cancer Institute (KCC) site for medical/systemic treatment for a new, confirmed diagnosis of stages I-IV cancer
Speak and read English well enough to be able to understand consent documents
Given the diverse population seen at KCI, we will make attempts to recruit a representative sample. Our strategy will be simply to ask recruiters to make special attempts to recruit a representative sample. If that strategy fails after the first 10 patients we will build in requirements that at least 25% of the patients self-identify as non-White

Patient Q&A Section

What is carcinoma, ovarian epithelial?

"The histologic term 'carcinoma, ovarian epithelial' is used frequently but has no clear definition. To avoid confusion, we propose that malignant neoplasms which are endometrial-type adenocarcinoma should be referred to as carcinoma, endometrial type (CEC), whereas those with a serous type should be called serous carcinoma. We also propose that tumors of the ovary, fallopian tube, primary peritoneal surface, and mesothelium should be included in the histological term carcinoma, ovarian epithelial." - Anonymous Online Contributor

Unverified Answer

What is the primary cause of carcinoma, ovarian epithelial?

"The main cause of carcinoma, ovarian epithelial, is related to a combination of factors including genetics, host immune response, environmental exposures, and viral infections. There is no single risk factor for all cases of carcinoma, ovarian epithelial. For those who do develop carcinoma, there are multiple risk factors associated with the disease progressing to malignancy." - Anonymous Online Contributor

Unverified Answer

What is the latest research for carcinoma, ovarian epithelial?

"Well-designed studies will clarify whether there are any differences between ovarian cancer cell lines. It should also be determined if there is a difference in survival rates among different types of ovarian cancers." - Anonymous Online Contributor

Unverified Answer

What are common treatments for carcinoma, ovarian epithelial?

"A new approach has been proposed to treat carcinoma of the ovary, and this therapy might be effective. Histological analysis of tumor samples obtained before and after chemotherapy showed that the most frequent changes observed were necrosis and apoptosis. Results from a recent clinical trial suggest that a combination regimen of chemotherapy and irradiation would be relevant to treat malignant tumors, such as ovarian carcinomas." - Anonymous Online Contributor

Unverified Answer

What does behavioral intervention usually treat?

"Behavioral interventions work to change behaviors deemed harmful and can reduce the risk of developing or worsening disease in those at high risk for chronic illness. Behavioral interventions are commonly used to change many health behaviors and are often combined with medication to improve outcomes. As a result, even if an individual chooses not to take a medication, it is possible that he or she will experience positive effects from the behavioral intervention. Results from a recent clinical trial provides evidence that partners can provide support to assist individuals' coping strategies and promote self-care behavior." - Anonymous Online Contributor

Unverified Answer

What is the survival rate for carcinoma, ovarian epithelial?

"Survival was lower when the disease was detected at an advanced stage; however, prognosis was better when the disease was detected at an early stage. The most important factor influencing survival was FIGO stage." - Anonymous Online Contributor

Unverified Answer

Can carcinoma, ovarian epithelial be cured?

"In 11 patients treated by TMJ surgery, there was no recurrence of first relapse. However, in one patient who was thought to be cured after TMJ surgery, there were signs of an unresectable tumor in the ipsilateral ovary. While many patients will not develop recurrent disease when treated by TMJ surgery alone, this case highlights the importance of early diagnosis and prompt surgical intervention when possible because the disease may recur in the ipsilateral ovary even without manifesting itself clinically." - Anonymous Online Contributor

Unverified Answer

Does behavioral intervention improve quality of life for those with carcinoma, ovarian epithelial?

"A combined behavioral intervention improved QOL for women with ovarian carcinoma. In particular, increased satisfaction with one's appearance, less interference with daily activities, and better sleep were associated with improved QOL. This intervention could be used as a component of a cancer rehabilitation program to help address patient concerns about QOL." - Anonymous Online Contributor

Unverified Answer

How quickly does carcinoma, ovarian epithelial spread?

"Although the study was limited because of its retrospective nature, the data indicate an average interval of 6 months between diagnosis and initial dissemination of carcinoma, and 7 months between dissemination and beginning of chemotherapy." - Anonymous Online Contributor

Unverified Answer

What is the average age someone gets carcinoma, ovarian epithelial?

"The average age of carcinoma, ovarian epithelial tumor patients is 63.2 years. This age range of onset was 64 to 76 yr in most cases. All cancers cause pain; however, carcinoma, ovarian epithelial causes the highest pain severity. There were no significant differences in time of cancer onset, stage, and symptom onset in menopausal women. There was no significant difference in time of disease onset, but the largest number of advanced stages was noted among premenopausal women." - Anonymous Online Contributor

Unverified Answer

What are the latest developments in behavioral intervention for therapeutic use?

"A variety of interventions have been developed for relapse prevention following exposure therapy for OCD at least since the late 1970s. Research in this domain continues to evolve. Behavioral interventions can be delivered using a range of delivery methods including self-help books, audiotapes, video tapes, and internet-based programs, among others." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
See if you qualify for this trial
Get access to this novel treatment for Ovary Cancer by sharing your contact details with the study coordinator.